Annual Shareholders Equity
$142.37 M
-$54.67 M-27.75%
December 31, 2023
Summary
- As of February 7, 2025, ACHL annual stockholders equity is $142.37 million, with the most recent change of -$54.67 million (-27.75%) on December 31, 2023.
- During the last 3 years, ACHL annual shareholders equity has fallen by -$47.00 million (-24.82%).
- ACHL annual shareholders equity is now -50.83% below its all-time high of $289.53 million, reached on December 31, 2021.
Performance
ACHL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$103.14 M
-$12.34 M-10.68%
September 1, 2024
Summary
- As of February 7, 2025, ACHL quarterly stockholders equity is $103.14 million, with the most recent change of -$12.34 million (-10.68%) on September 1, 2024.
- Over the past year, ACHL quarterly shareholders equity has dropped by -$39.23 million (-27.56%).
- ACHL quarterly shareholders equity is now -68.16% below its all-time high of $323.97 million, reached on June 30, 2021.
Performance
ACHL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ACHL Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.8% | -27.6% |
| 3 y3 years | -24.8% | -49.1% |
| 5 y5 years | +40.5% | -49.1% |
ACHL Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.8% | at low | -64.4% | at low |
| 5 y | 5-year | -50.8% | +40.5% | -68.2% | at low |
| alltime | all time | -50.8% | +40.5% | -68.2% | at low |
Achilles Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $103.14 M(-10.7%) |
| Jun 2024 | - | $115.47 M(-11.4%) |
| Mar 2024 | - | $130.35 M(-8.4%) |
| Dec 2023 | $142.37 M(-27.7%) | $142.37 M(-7.2%) |
| Sep 2023 | - | $153.49 M(-11.7%) |
| Jun 2023 | - | $173.84 M(-6.1%) |
| Mar 2023 | - | $185.17 M(-6.0%) |
| Dec 2022 | $197.04 M | $197.04 M(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $202.62 M(-12.5%) |
| Jun 2022 | - | $231.59 M(-13.1%) |
| Mar 2022 | - | $266.45 M(-8.0%) |
| Dec 2021 | $289.53 M(+52.9%) | $289.53 M(-5.1%) |
| Sep 2021 | - | $305.11 M(-5.8%) |
| Jun 2021 | - | $323.97 M(+80.9%) |
| Mar 2021 | - | $179.05 M(-5.4%) |
| Dec 2020 | $189.37 M(+86.9%) | $189.37 M |
| Dec 2019 | $101.35 M | - |
FAQ
- What is Achilles Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Achilles Therapeutics?
- What is Achilles Therapeutics annual shareholders equity year-on-year change?
- What is Achilles Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Achilles Therapeutics?
- What is Achilles Therapeutics quarterly shareholders equity year-on-year change?
What is Achilles Therapeutics annual stockholders equity?
The current annual shareholders equity of ACHL is $142.37 M
What is the all time high annual shareholders equity for Achilles Therapeutics?
Achilles Therapeutics all-time high annual stockholders equity is $289.53 M
What is Achilles Therapeutics annual shareholders equity year-on-year change?
Over the past year, ACHL annual stockholders equity has changed by -$54.67 M (-27.75%)
What is Achilles Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ACHL is $103.14 M
What is the all time high quarterly shareholders equity for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly stockholders equity is $323.97 M
What is Achilles Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ACHL quarterly stockholders equity has changed by -$39.23 M (-27.56%)